These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 10791121)

  • 21. Renal sodium handling and nighttime blood pressure.
    Burnier M; Coltamai L; Maillard M; Bochud M
    Semin Nephrol; 2007 Sep; 27(5):565-71. PubMed ID: 17868794
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Target hemoglobin level for EPO therapy in CKD.
    Parfrey PS
    Am J Kidney Dis; 2006 Jan; 47(1):171-3. PubMed ID: 16377399
    [No Abstract]   [Full Text] [Related]  

  • 23. Hypertension and future cardiovascular disease in pediatric renal transplant recipients.
    Flynn JT
    Pediatr Transplant; 2006 May; 10(3):276-8. PubMed ID: 16677348
    [No Abstract]   [Full Text] [Related]  

  • 24. [What are the aims and targets of renal anemia therapy?].
    Eckardt KU
    Dtsch Med Wochenschr; 2007 Sep; 132(36):1837-41. PubMed ID: 17726657
    [No Abstract]   [Full Text] [Related]  

  • 25. [Ionized magnesium: its value in functional pathology].
    Dubois F; Tomasini S; Duc ML; Duc M; Belleville F
    Ann Biol Clin (Paris); 1997; 55(6):639-40. PubMed ID: 9499933
    [No Abstract]   [Full Text] [Related]  

  • 26. Lipid abnormalities and cardiovascular risk in renal disease.
    Ritz E; Wanner C
    J Am Soc Nephrol; 2008 Jun; 19(6):1065-70. PubMed ID: 18369085
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel biomedical risk markers for cardiovascular disease.
    Magliano DJ; Liew D; Ashton EL; Sundararajan V; McNeil JJ
    J Cardiovasc Risk; 2003 Feb; 10(1):41-55. PubMed ID: 12569236
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Renal function impairment in peripheral arterial disease: an important parameter that should not be neglected.
    Paraskevas KI; Giannoukas AD; Mikhailidis DP
    Ann Vasc Surg; 2009; 23(5):690-9. PubMed ID: 19747617
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cardiovascular disease in renal patients--a matter of stem cells?
    Fliser D; de Groot K; Bahlmann FH; Haller H
    Nephrol Dial Transplant; 2004 Dec; 19(12):2952-4. PubMed ID: 15574993
    [No Abstract]   [Full Text] [Related]  

  • 30. Second chances in mineral metabolism.
    Wolf M
    Clin J Am Soc Nephrol; 2010 Jan; 5(1):1-3. PubMed ID: 20007676
    [No Abstract]   [Full Text] [Related]  

  • 31. Dialysis catheter insertion with and without peel-away sheaths.
    Polakovic V; Svára F; Dvoráková M
    Nephrol Dial Transplant; 2007 Aug; 22(8):2359. PubMed ID: 17504844
    [No Abstract]   [Full Text] [Related]  

  • 32. Is homocysteine toxic in uremia?
    Perna AF; Luciano MG; Pulzella P; Satta E; Capasso R; Lombardi C; Ingrosso D; De Santo NG
    J Ren Nutr; 2008 Jan; 18(1):12-7. PubMed ID: 18089438
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Extracellular volume and aldosterone interaction in chronic kidney disease.
    Klemmer PJ; Bomback AS
    Blood Purif; 2009; 27(1):92-8. PubMed ID: 19169025
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Homocysteine and atherothrombosis.
    Nath KA
    N Engl J Med; 1998 Aug; 339(7):478-9. PubMed ID: 9705691
    [No Abstract]   [Full Text] [Related]  

  • 35. Plasma reduced homocysteine and other aminothiol concentrations in patients with CKD.
    Sjöberg B; Anderstam B; Suliman M; Alvestrand A
    Am J Kidney Dis; 2006 Jan; 47(1):60-71. PubMed ID: 16377386
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [A major vascular risk factor: mild impairment of renal function].
    Tepel M
    MMW Fortschr Med; 2003 Apr; 145(15):51-2. PubMed ID: 15104267
    [No Abstract]   [Full Text] [Related]  

  • 37. Hypertension in chronic kidney disease and dialysis: pathophysiology and management.
    Agarwal R
    Cardiol Clin; 2005 Aug; 23(3):237-48. PubMed ID: 16084275
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Chronic kidney disease and statins].
    Matovinović MS
    Lijec Vjesn; 2006; 128(11-12):345-50. PubMed ID: 17212196
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lipid management in chronic kidney disease, hemodialysis, and transplantation.
    Montague T; Murphy B
    Endocrinol Metab Clin North Am; 2009 Mar; 38(1):223-34. PubMed ID: 19217521
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Urotensin-II as a novel therapeutic target in the clinical management of cardiorenal disease.
    Gilbert RE; Douglas SA; Krum H
    Curr Opin Investig Drugs; 2004 Mar; 5(3):276-82. PubMed ID: 15083593
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.